Delivery Order SPE2DB20D3101-SPE2DB25FQUC2

Award Date 11/1/24
Potential Completion Date 11/25/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,855.58 firm fixed price delivery order is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of July 15, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This contract award to Amerisourcebergen Drug Corp is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The awarded Delivery Order, valued at $4,611.84, is for the pharmaceutical product Somatuline Depot 90 mg/0.3 mL 0.3mL. This contract has no set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor and...
This federal contract award, valued at $17,378.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty medication, with a completion date of November 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,228.89 fixed-price delivery order is for the supply of Somatuline Depot, a specialty medication used for the treatment of certain medical conditions. The contract has a completion date of November 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide a specialty pharmaceutical product, Somatuline Depot 120 mg/0.5 ml. The award, valued at $2,896.41, has an ultimate completion date of April 10, 2024. AmerisourceBergen Drug Corp serves as a prime contractor for DLA, providing a wide range of pharmaceutical products and medical supplies to...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,951.86, is a delivery order for the specialty medication Somatuline Depot 120 mg/0.5 mL. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through March 2025. No set-aside designation was used for this contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of Somatuline Depot 120 mg/0.5 ml pharmaceutical products. The contract, valued at $2,896.41, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). AmerisourceBergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of major pharmaceutical distributor Amerisourcebergen Corporation, is for the supply of the prescription drug Somatuline Depot 90 mg/0.3 ml to the Defense Logistics Agency (DLA). The $2,228.89 firm fixed price delivery order, which is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, does not have a set-aside designation. The IDC serves as the...
This federal contract award, valued at $11,585.64, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the delivery of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of October 4, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical supplies and prescription drugs to various...
The Department of Defense's Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $2,228.89 contract is for the delivery of Somatuline Depot 90 mg/0.3 ml medication, with a performance period ending on February 23, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FQUC2
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The contract covers the delivery of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty pharmaceutical product, to support military healthcare programs. The award, valued at $2,896.41, has a firm fixed price and an ultimate completion date of November 25, 2024. The contract is not designated with a set-aside requirement, indicating open competition. As a major pharmaceutical distributor and healthcare solutions provider, Amerisourcebergen plays a critical role in supplying a broad range of medical products, including specialty medications, generic drugs, and medical devices, to various federal agencies and healthcare programs.

Generated 1/31/25, 9:06 AM